Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 8653 to 8661 of 8661 entries
Sorted by: Best Match Show Resources per page
Establishment of a Macrophage Phenotypic Switch Related Prognostic Signature in Patients With Pancreatic Cancer.

Frontiers in oncology

Li MX, Wang HY, Yuan CH, Ma ZL, Jiang B, Li L, Zhang L, Xiu DR.
PMID: 33747931
Front Oncol. 2021 Mar 03;11:619517. doi: 10.3389/fonc.2021.619517. eCollection 2021.

INTRODUCTION: Macrophage phenotype switch plays a vital role in the progression of malignancies. We aimed to build a prognostic signature by exploring the expression pattern of macrophage phenotypic switch related genes (MRGs) in the Cancer Genome Atlas (TCGA)-pancreatic adenocarcinoma...

Cite
Li MX, Wang HY, Yuan CH, et al. Establishment of a Macrophage Phenotypic Switch Related Prognostic Signature in Patients With Pancreatic Cancer. Front Oncol. 2021;11:619517doi: 10.3389/fonc.2021.619517.
Li, M. X., Wang, H. Y., Yuan, C. H., Ma, Z. L., Jiang, B., Li, L., Zhang, L., & Xiu, D. R. (2021). Establishment of a Macrophage Phenotypic Switch Related Prognostic Signature in Patients With Pancreatic Cancer. Frontiers in oncology, 11619517. https://doi.org/10.3389/fonc.2021.619517
Li, Mu-Xing, et al. "Establishment of a Macrophage Phenotypic Switch Related Prognostic Signature in Patients With Pancreatic Cancer." Frontiers in oncology vol. 11 (2021): 619517. doi: https://doi.org/10.3389/fonc.2021.619517
Li MX, Wang HY, Yuan CH, Ma ZL, Jiang B, Li L, Zhang L, Xiu DR. Establishment of a Macrophage Phenotypic Switch Related Prognostic Signature in Patients With Pancreatic Cancer. Front Oncol. 2021 Mar 03;11:619517. doi: 10.3389/fonc.2021.619517. eCollection 2021. PMID: 33747931; PMCID: PMC7966706.
Copy Download .nbib Format: NLM
Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence.

Biomaterials

Zhang XP, Chen XJ, Li BZ, Xu S, Wu ZL, Hu MG, Zhao ZM, Zhao GD, Wang CR, Hong W, Li SP, Li L, Wang CG, Nie G, Liu R.
PMID: 34998170
Biomaterials. 2022 Jan 04;281:121362. doi: 10.1016/j.biomaterials.2022.121362. Epub 2022 Jan 04.

Surgery is one of the main effective strategies for the treatment of solid tumors, but high postoperative recurrence is also the main cause of death in current cancer therapy. The prevention of postoperative hepatocellular carcinoma (HCC) recurrence is a...

Cite
Zhang XP, Chen XJ, Li BZ, et al. Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence. Biomaterials. 2022;281:121362doi: 10.1016/j.biomaterials.2022.121362.
Zhang, X. P., Chen, X. J., Li, B. Z., Xu, S., Wu, Z. L., Hu, M. G., Zhao, Z. M., Zhao, G. D., Wang, C. R., Hong, W., Li, S. P., Li, L., Wang, C. G., Nie, G., & Liu, R. (2022). Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence. Biomaterials, 281121362. https://doi.org/10.1016/j.biomaterials.2022.121362
Zhang, Xiu-Ping, et al. "Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence." Biomaterials vol. 281 (2022): 121362. doi: https://doi.org/10.1016/j.biomaterials.2022.121362
Zhang XP, Chen XJ, Li BZ, Xu S, Wu ZL, Hu MG, Zhao ZM, Zhao GD, Wang CR, Hong W, Li SP, Li L, Wang CG, Nie G, Liu R. Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence. Biomaterials. 2022 Jan 04;281:121362. doi: 10.1016/j.biomaterials.2022.121362. Epub 2022 Jan 04. PMID: 34998170.
Copy Download .nbib Format: NLM
Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?.

Journal of molecular medicine (Berlin, Germany)

Weng CH, Wu RC, Chen SJ, Chen HC, Tan KT, Lee YS, Huang SS, Yang LY, Wang CJ, Chou HH, Chao AS, Chao A, Lai CH.
PMID: 33768299
J Mol Med (Berl). 2021 Jul;99(7):959-966. doi: 10.1007/s00109-021-02064-4. Epub 2021 Mar 25.

Synchronous endometrial and ovarian carcinomas (SEOCs) that share the same endometrioid histology are generally considered as the result of metastatic spread from one organ to another. However, SEOCs with different histologies are regarded as distinct primary lesions that arise...

Cite
Weng CH, Wu RC, Chen SJ, et al. Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?. J Mol Med (Berl). 2021;99(7):959-966doi: 10.1007/s00109-021-02064-4.
Weng, C. H., Wu, R. C., Chen, S. J., Chen, H. C., Tan, K. T., Lee, Y. S., Huang, S. S., Yang, L. Y., Wang, C. J., Chou, H. H., Chao, A. S., Chao, A., & Lai, C. H. (2021). Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?. Journal of molecular medicine (Berlin, Germany), 99(7), 959-966. https://doi.org/10.1007/s00109-021-02064-4
Weng, Cindy Hsuan, et al. "Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?." Journal of molecular medicine (Berlin, Germany) vol. 99,7 (2021): 959-966. doi: https://doi.org/10.1007/s00109-021-02064-4
Weng CH, Wu RC, Chen SJ, Chen HC, Tan KT, Lee YS, Huang SS, Yang LY, Wang CJ, Chou HH, Chao AS, Chao A, Lai CH. Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?. J Mol Med (Berl). 2021 Jul;99(7):959-966. doi: 10.1007/s00109-021-02064-4. Epub 2021 Mar 25. PMID: 33768299.
Copy Download .nbib Format: NLM
Outcomes of pregnancy in autoimmune hepatitis: A population-based study.

Hepatology (Baltimore, Md.)

Wang CW, Grab J, Tana MM, Irani RA, Sarkar M.
PMID: 34455632
Hepatology. 2021 Aug 28; doi: 10.1002/hep.32132. Epub 2021 Aug 28.

BACKGROUND AND AIMS: Autoimmune hepatitis (AIH) disproportionately affects young women, which may have implications in pregnancy. However, data on pregnancy outcomes in women with AIH are limited.APPROACH AND RESULTS: Using weighted discharge data from the United States National Inpatient...

Cite
Wang CW, Grab J, Tana MM, et al. Outcomes of pregnancy in autoimmune hepatitis: A population-based study. Hepatology. 2021;doi: 10.1002/hep.32132.
Wang, C. W., Grab, J., Tana, M. M., Irani, R. A., & Sarkar, M. (2021). Outcomes of pregnancy in autoimmune hepatitis: A population-based study. Hepatology (Baltimore, Md.), . https://doi.org/10.1002/hep.32132
Wang, Connie W, et al. "Outcomes of pregnancy in autoimmune hepatitis: A population-based study." Hepatology (Baltimore, Md.) vol. (2021). doi: https://doi.org/10.1002/hep.32132
Wang CW, Grab J, Tana MM, Irani RA, Sarkar M. Outcomes of pregnancy in autoimmune hepatitis: A population-based study. Hepatology. 2021 Aug 28; doi: 10.1002/hep.32132. Epub 2021 Aug 28. PMID: 34455632.
Copy Download .nbib Format: NLM
Enhanced wettability performance of ultrathin ZnO nanotubes by coupling morphology and size effects.

Nanoscale

Yang P, Wang K, Liang Z, Mai W, Wang CX, Xie W, Liu P, Zhang L, Cai X, Tan S, Song J.
PMID: 22895660
Nanoscale. 2012 Sep 21;4(18):5755-60. doi: 10.1039/c2nr31380d. Epub 2012 Aug 16.

In this work, we report on the detailed characterization and mechanism analysis of the improved wettability performance of a new type of ZnO nanostructure, the ultrathin ZnO nanotube, whose growth is induced by screw-dislocation. The newly discovered enhanced wettability...

Cite
Yang P, Wang K, Liang Z, et al. Enhanced wettability performance of ultrathin ZnO nanotubes by coupling morphology and size effects. Nanoscale. 2012;4(18):5755-60doi: 10.1039/c2nr31380d.
Yang, P., Wang, K., Liang, Z., Mai, W., Wang, C. X., Xie, W., Liu, P., Zhang, L., Cai, X., Tan, S., & Song, J. (2012). Enhanced wettability performance of ultrathin ZnO nanotubes by coupling morphology and size effects. Nanoscale, 4(18), 5755-60. https://doi.org/10.1039/c2nr31380d
Yang, Peihua, et al. "Enhanced wettability performance of ultrathin ZnO nanotubes by coupling morphology and size effects." Nanoscale vol. 4,18 (2012): 5755-60. doi: https://doi.org/10.1039/c2nr31380d
Yang P, Wang K, Liang Z, Mai W, Wang CX, Xie W, Liu P, Zhang L, Cai X, Tan S, Song J. Enhanced wettability performance of ultrathin ZnO nanotubes by coupling morphology and size effects. Nanoscale. 2012 Sep 21;4(18):5755-60. doi: 10.1039/c2nr31380d. Epub 2012 Aug 16. PMID: 22895660.
Copy Download .nbib Format: NLM
The "wrap-guided bone regeneration (GBR)-technique" is a predicted and stable way for alveolar cleft repair and dental implant placement.

Journal of dental sciences

Huang YW, Tseng CW, Yu CH, Fang CY.
PMID: 34484612
J Dent Sci. 2021 Oct;16(4):1328-1330. doi: 10.1016/j.jds.2021.02.005. Epub 2021 Mar 02.

No abstract available.

Cite
Huang YW, Tseng CW, Yu CH, et al. The "wrap-guided bone regeneration (GBR)-technique" is a predicted and stable way for alveolar cleft repair and dental implant placement. J Dent Sci. 2021;16(4):1328-1330doi: 10.1016/j.jds.2021.02.005.
Huang, Y. W., Tseng, C. W., Yu, C. H., & Fang, C. Y. (2021). The "wrap-guided bone regeneration (GBR)-technique" is a predicted and stable way for alveolar cleft repair and dental implant placement. Journal of dental sciences, 16(4), 1328-1330. https://doi.org/10.1016/j.jds.2021.02.005
Huang, Yen-Wen, et al. "The "wrap-guided bone regeneration (GBR)-technique" is a predicted and stable way for alveolar cleft repair and dental implant placement." Journal of dental sciences vol. 16,4 (2021): 1328-1330. doi: https://doi.org/10.1016/j.jds.2021.02.005
Huang YW, Tseng CW, Yu CH, Fang CY. The "wrap-guided bone regeneration (GBR)-technique" is a predicted and stable way for alveolar cleft repair and dental implant placement. J Dent Sci. 2021 Oct;16(4):1328-1330. doi: 10.1016/j.jds.2021.02.005. Epub 2021 Mar 02. PMID: 34484612; PMCID: PMC8403890.
Copy Download .nbib Format: NLM
Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial.

Journal of asthma and allergy

Corren J, Saini SS, Gagnon R, Moss MH, Sussman G, Jacobs J, Laws E, Chung ES, Constant T, Sun Y, Maloney J, Hamilton JD, Ruddy M, Wang CQ, O'Brien MP.
PMID: 34429614
J Asthma Allergy. 2021 Aug 16;14:1045-1063. doi: 10.2147/JAA.S318892. eCollection 2021.

BACKGROUND: Subcutaneous immunotherapy (SCIT) has been proven as an effective therapy against some allergens for seasonal allergic rhinitis (SAR) patients unresponsive to intranasal corticosteroids and/or antihistamines but carries risk of systemic allergic reactions. Dupilumab blocks the shared receptor component...

Cite
Corren J, Saini SS, Gagnon R, et al. Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial. J Asthma Allergy. 2021;14:1045-1063doi: 10.2147/JAA.S318892.
Corren, J., Saini, S. S., Gagnon, R., Moss, M. H., Sussman, G., Jacobs, J., Laws, E., Chung, E. S., Constant, T., Sun, Y., Maloney, J., Hamilton, J. D., Ruddy, M., Wang, C. Q., & O'Brien, M. P. (2021). Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial. Journal of asthma and allergy, 141045-1063. https://doi.org/10.2147/JAA.S318892
Corren, Jonathan, et al. "Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial." Journal of asthma and allergy vol. 14 (2021): 1045-1063. doi: https://doi.org/10.2147/JAA.S318892
Corren J, Saini SS, Gagnon R, Moss MH, Sussman G, Jacobs J, Laws E, Chung ES, Constant T, Sun Y, Maloney J, Hamilton JD, Ruddy M, Wang CQ, O'Brien MP. Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial. J Asthma Allergy. 2021 Aug 16;14:1045-1063. doi: 10.2147/JAA.S318892. eCollection 2021. PMID: 34429614; PMCID: PMC8379710.
Copy Download .nbib Format: NLM
First report of an adult female patient with endobronchial inflammatory myofibroblastic tumor in Taiwan: A case report.

Thoracic cancer

Lin YT, Huang SH, Chang CH, Hsu PC, Wang CW, Lee CS.
PMID: 34520108
Thorac Cancer. 2021 Oct;12(20):2807-2810. doi: 10.1111/1759-7714.14104. Epub 2021 Sep 14.

An inflammatory myofibroblastic tumor (IMT) of the respiratory system is an uncommon disease. In Taiwan, there is a lack of previous studies on tracheobronchial IMT. The tumor is characterized by overexpression of anaplastic lymphoma receptor tyrosine kinase (ALK)-1. Surgical...

Cite
Lin YT, Huang SH, Chang CH, et al. First report of an adult female patient with endobronchial inflammatory myofibroblastic tumor in Taiwan: A case report. Thorac Cancer. 2021;12(20):2807-2810doi: 10.1111/1759-7714.14104.
Lin, Y. T., Huang, S. H., Chang, C. H., Hsu, P. C., Wang, C. W., & Lee, C. S. (2021). First report of an adult female patient with endobronchial inflammatory myofibroblastic tumor in Taiwan: A case report. Thoracic cancer, 12(20), 2807-2810. https://doi.org/10.1111/1759-7714.14104
Lin, Yan-Ting, et al. "First report of an adult female patient with endobronchial inflammatory myofibroblastic tumor in Taiwan: A case report." Thoracic cancer vol. 12,20 (2021): 2807-2810. doi: https://doi.org/10.1111/1759-7714.14104
Lin YT, Huang SH, Chang CH, Hsu PC, Wang CW, Lee CS. First report of an adult female patient with endobronchial inflammatory myofibroblastic tumor in Taiwan: A case report. Thorac Cancer. 2021 Oct;12(20):2807-2810. doi: 10.1111/1759-7714.14104. Epub 2021 Sep 14. PMID: 34520108; PMCID: PMC8520803.
Copy Download .nbib Format: NLM
Neural network prediction of 30-day mortality following primary total hip arthroplasty.

Journal of orthopaedics

Fassihi SC, Mathur A, Best MJ, Chen AZ, Gu A, Quan T, Wang KY, Wei C, Campbell JC, Thakkar SC.
PMID: 34898926
J Orthop. 2021 Nov 25;28:91-95. doi: 10.1016/j.jor.2021.11.013. eCollection 2021.

PURPOSE: The purpose is to utilize an artificial neural network (ANN) model to determine the most important variables in predicting mortality following total hip arthroplasty (THA).METHODS: Patients that underwent primary THA were included from a national database. Demographic, preoperative,...

Cite
Fassihi SC, Mathur A, Best MJ, et al. Neural network prediction of 30-day mortality following primary total hip arthroplasty. J Orthop. 2021;28:91-95doi: 10.1016/j.jor.2021.11.013.
Fassihi, S. C., Mathur, A., Best, M. J., Chen, A. Z., Gu, A., Quan, T., Wang, K. Y., Wei, C., Campbell, J. C., & Thakkar, S. C. (2021). Neural network prediction of 30-day mortality following primary total hip arthroplasty. Journal of orthopaedics, 2891-95. https://doi.org/10.1016/j.jor.2021.11.013
Fassihi, Safa C, et al. "Neural network prediction of 30-day mortality following primary total hip arthroplasty." Journal of orthopaedics vol. 28 (2021): 91-95. doi: https://doi.org/10.1016/j.jor.2021.11.013
Fassihi SC, Mathur A, Best MJ, Chen AZ, Gu A, Quan T, Wang KY, Wei C, Campbell JC, Thakkar SC. Neural network prediction of 30-day mortality following primary total hip arthroplasty. J Orthop. 2021 Nov 25;28:91-95. doi: 10.1016/j.jor.2021.11.013. eCollection 2021. PMID: 34898926; PMCID: PMC8636995.
Copy Download .nbib Format: NLM
Showing 8653 to 8661 of 8661 entries